News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
788,890 Results
Type
Article (69343)
Company Profile (690)
Press Release (718857)
Multimedia
Podcasts (111)
Webinars (13)
Section
Business (221058)
Career Advice (3529)
Deals (37669)
Drug Delivery (127)
Drug Development (87542)
Employer Resources (192)
FDA (17623)
Job Trends (16428)
News (375181)
Policy (36302)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (19)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (13)
2025 Lone Star Bio Digital (16)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2978)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (89)
Alliances (53477)
ALS (96)
Alzheimer's disease (1486)
Antibody-drug conjugate (ADC) (143)
Approvals (17588)
Artificial intelligence (299)
Autoimmune disease (28)
Automation (15)
Bankruptcy (359)
Best Places to Work (12602)
BIOSECURE Act (21)
Biosimilars (118)
Biotechnology (476)
Bladder cancer (67)
Brain cancer (30)
Breast cancer (286)
Cancer (2249)
Cardiovascular disease (195)
Career advice (2979)
Career pathing (33)
CAR-T (164)
Cell therapy (465)
Cervical cancer (21)
Clinical research (70595)
Collaboration (867)
Compensation (524)
Complete response letters (29)
COVID-19 (2795)
CRISPR (45)
C-suite (243)
Cystic fibrosis (107)
Data (2106)
Decentralized trials (2)
Denatured (30)
Depression (51)
Diabetes (281)
Diagnostics (6863)
Digital health (20)
Diversity (6)
Diversity, equity & inclusion (45)
Drug discovery (144)
Drug pricing (120)
Drug shortages (33)
Duchenne muscular dystrophy (99)
Earnings (92245)
Editorial (43)
Employer branding (25)
Employer resources (161)
Events (125931)
Executive appointments (738)
FDA (18873)
Featured Employer (58)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (778)
Gene editing (115)
Generative AI (30)
Gene therapy (337)
GLP-1 (834)
Government (4982)
Grass and pollen (5)
Guidances (51)
Healthcare (20824)
Huntington's disease (25)
IgA nephropathy (27)
Immunology and inflammation (138)
Indications (27)
Infectious disease (2951)
Inflammatory bowel disease (149)
Inflation Reduction Act (11)
Influenza (56)
Intellectual property (95)
Interviews (675)
IPO (17542)
IRA (49)
Job creations (4319)
Job search strategy (2453)
Kidney cancer (10)
Labor market (40)
Layoffs (534)
Leadership (21)
Legal (8714)
Liver cancer (77)
Lung cancer (325)
Lymphoma (144)
Machine learning (5)
Management (63)
Manufacturing (325)
MASH (70)
Medical device (14514)
Medtech (14519)
Mergers & acquisitions (20684)
Metabolic disorders (750)
Multiple sclerosis (81)
NASH (23)
Neurodegenerative disease (106)
Neuropsychiatric disorders (31)
Neuroscience (2055)
NextGen: Class of 2025 (7577)
Non-profit (5053)
Northern California (2600)
Now hiring (39)
Obesity (409)
Opinion (272)
Ovarian cancer (76)
Pain (92)
Pancreatic cancer (83)
Parkinson's disease (157)
Partnered (22)
Patents (238)
Patient recruitment (103)
Peanut (51)
People (62085)
Pharmaceutical (142)
Pharmacy benefit managers (21)
Phase I (21908)
Phase II (30826)
Phase III (23249)
Pipeline (1163)
Policy (159)
Postmarket research (3059)
Preclinical (9604)
Press Release (69)
Prostate cancer (103)
Psychedelics (38)
Radiopharmaceuticals (268)
Rare diseases (419)
Real estate (6839)
Recruiting (74)
Regulatory (24822)
Reports (50)
Research institute (2633)
Resumes & cover letters (563)
Rett syndrome (4)
RNA editing (4)
RSV (49)
Schizophrenia (77)
Series A (136)
Series B (87)
Service/supplier (29)
Sickle cell disease (58)
Southern California (2257)
Special edition (18)
Spinal muscular atrophy (160)
Sponsored (33)
Startups (3908)
State (2)
Stomach cancer (16)
Supply chain (72)
Tariffs (29)
The Weekly (79)
United States (23509)
Vaccines (771)
Venture capitalists (41)
Weight loss (295)
Women's health (34)
Worklife (19)
Date
Last 7 days (513)
Last 30 days (2315)
Last 365 days (35718)
2025 (10153)
2024 (38027)
2023 (42517)
2022 (53863)
2021 (58636)
2020 (57551)
2019 (51143)
2018 (38855)
2017 (36027)
2016 (36337)
2015 (42182)
2014 (36634)
2013 (33715)
2012 (33661)
2011 (34114)
2010 (33047)
Location
Africa (1070)
Alabama (58)
Alaska (7)
Arizona (227)
Arkansas (14)
Asia (45986)
Australia (8138)
California (6064)
Canada (1980)
China (526)
Colorado (269)
Connecticut (290)
Delaware (145)
Europe (105626)
Florida (889)
Georgia (215)
Hawaii (1)
Idaho (62)
Illinois (594)
India (29)
Indiana (324)
Iowa (10)
Japan (154)
Kansas (109)
Kentucky (27)
Louisiana (13)
Maine (70)
Maryland (927)
Massachusetts (4688)
Michigan (240)
Minnesota (405)
Mississippi (2)
Missouri (88)
Montana (30)
Nebraska (25)
Nevada (62)
New Hampshire (68)
New Jersey (1744)
New Mexico (31)
New York (1726)
North Carolina (1091)
North Dakota (8)
Northern California (2600)
Ohio (209)
Oklahoma (15)
Oregon (47)
Pennsylvania (1349)
Puerto Rico (12)
Rhode Island (33)
South America (1435)
South Carolina (21)
South Dakota (1)
Southern California (2257)
Tennessee (102)
Texas (918)
Utah (182)
Virginia (160)
Washington D.C. (67)
Washington State (583)
West Virginia (3)
Wisconsin (65)
788,890 Results for "the nasdaq stock market new york".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX
March 31, 2025
·
3 min read
Press Releases
Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel
March 6, 2025
·
4 min read
Press Releases
Dogwood Therapeutics, Inc. Announces Pricing of $4.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
March 13, 2025
·
5 min read
Press Releases
Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules
January 15, 2025
·
3 min read
Press Releases
Ensysce Biosciences, Inc. Announces $1.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
April 1, 2025
·
5 min read
Press Releases
Jaguar Health Announces Closing of Bridge Financing Priced At-The-Market Under Nasdaq Rules
April 2, 2025
·
5 min read
Job Trends
5 Biopharma Companies Hiring in New York
Check out five New York companies hiring biopharma professionals like you, including 2025 Best Places to Work winners.
November 21, 2024
·
1 min read
·
Chantal Dresner
Press Releases
BioSig Technologies Confirms Full Compliance with Nasdaq Requirements for Continued Listing on The Nasdaq Capital Market
March 27, 2025
·
4 min read
Press Releases
Aptevo Therapeutics $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
April 3, 2025
·
7 min read
Press Releases
Dermata Therapeutics Announces Exercise of Warrants for $6.2 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
March 28, 2025
·
6 min read
1 of 78,889
Next
